Clinical Trial to Evaluate the Safety and Efficacy of IM19 CAR-T Cells in Patients With Relapsed and Refractory (R/R) B-cell Acute Lymphoblastic Leukemia
Condition: Leukemia Intervention: Biological: IM19 CAR-T cells Sponsor: Beijing Immunochina Medical Science& Technology Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 4, 2022 Category: Research Source Type: clinical trials
Clinical Trial to Evaluate the Safety and Efficacy of IM96 CAR-T Cells Therapy in Patients With Advanced Digestive System Neoplasms
Conditions: Advanced Solid Tumors; Digestive System Neoplasms; Pancreatic Cancer Resectable; Colorectal (Colon or Rectal) Cancer Intervention: Drug: IM96 CAR-T cells Sponsor: Beijing Immunochina Medical Science& Technology Co., Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 18, 2022 Category: Research Source Type: clinical trials